Cargando…

Integration of the Tumor Mutational Burden and Tumor Heterogeneity Identify an Immunological Subtype of Melanoma With Favorable Survival

The tumor mutational burden (TMB) has been reported as a predictive marker of the response to immune checkpoint inhibition (ICI) therapy in previous melanoma clinical trials. However, the TMB alone is not sufficient to accurately predict immunotherapy benefit. Additional biomarkers are needed for be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Yanmei, Yang, Chunhe, He, Ning, Zhao, Guodong, Wang, Jianfei, Yang, Yadong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661856/ https://www.ncbi.nlm.nih.gov/pubmed/33194669 http://dx.doi.org/10.3389/fonc.2020.571545

Ejemplares similares

Mutant-Allele Tumor Heterogeneity, a Favorable Biomarker to Assess Intra-Tumor Heterogeneity, in Advanced Lung Adenocarcinoma
por: Wu, Xiaoxuan, et al.
Publicado: (2022)

Unraveling tumor microenvironment heterogeneity in malignant pleural mesothelioma identifies biologically distinct immune subtypes enabling prognosis determination
por: Yang, Kaidi, et al.
Publicado: (2022)

Significance of Tumor Mutation Burden in Immune Infiltration and Prognosis in Cutaneous Melanoma
por: Kang, Kai, et al.
Publicado: (2020)

Reveal the Heterogeneity in the Tumor Microenvironment of Pancreatic Cancer and Analyze the Differences in Prognosis and Immunotherapy Responses of Distinct Immune Subtypes
por: Wang, Xiaoqin, et al.
Publicado: (2022)

Aneuploid subtypes of circulating tumor cells and circulating tumor-derived endothelial cells predict the overall survival of advanced lung cancer
por: Zhang, Jie, et al.
Publicado: (2023)

The Human Cytomegalovirus US31 Gene Predicts Favorable Survival and Regulates the Tumor Microenvironment in Gastric Cancer
por: Ye, Sisi, et al.
Publicado: (2021)

Editorial: New Insights into the Complexity of Tumor Immunology in B-cell Malignancies: Tumor Immunology and Immunotherapy
por: Seiffert, Martina, et al.
Publicado: (2022)

Erratum: The Human Cytomegalovirus US31 Gene Predicts Favorable Survival and Regulates the Tumor Microenvironment in Gastric Cancer
Publicado: (2021)

Lipid metabolism in tumor immunology and immunotherapy
por: Duong, Lisa K., et al.
Publicado: (2023)

The Intratumor Microbiota Signatures Associate With Subtype, Tumor Stage, and Survival Status of Esophageal Carcinoma
por: Wang, Yangyang, et al.
Publicado: (2021)

Transcriptomic Analysis Identified Two Subtypes of Brain Tumor Characterized by Distinct Immune Infiltration and Prognosis
por: Shen, Xilin, et al.
Publicado: (2021)

The Clinical Implications of Tumor Mutational Burden in Osteosarcoma
por: Xie, Lu, et al.
Publicado: (2021)

Intratumor Heterogeneity Correlates With Reduced Immune Activity and Worse Survival in Melanoma Patients
por: Lin, Zhen, et al.
Publicado: (2020)

Higher Mutation Burden in High Proliferation Compartments of Heterogeneous Melanoma Tumors
por: Grzywa, Tomasz M., et al.
Publicado: (2021)

Identifying tumor antigens and immune subtypes of gastrointestinal MALT lymphoma for immunotherapy development
por: Jiang, Xinlu, et al.
Publicado: (2022)

Beyond Tumor Mutation Burden: Tumor Neoantigen Burden as a Biomarker for Immunotherapy and Other Types of Therapy
por: Wang, Peipei, et al.
Publicado: (2021)

Emerging Understanding of Multiscale Tumor Heterogeneity
por: Gerdes, Michael J., et al.
Publicado: (2014)

Prognostic Role of Tumor Mutation Burden Combined With Immune Infiltrates in Skin Cutaneous Melanoma Based on Multi-Omics Analysis
por: Yan, Junya, et al.
Publicado: (2020)

The Favorable Prognostic Factors for Superior Sulcus Tumor: A Systematic Review and Meta-Analysis
por: Hao, Xiaohu, et al.
Publicado: (2020)

Inflammatory myofibroblastic tumor of the urinary bladder: A prognostically favorable spindle cell neoplasm
por: Laylo, John Carlo V., et al.
Publicado: (2020)

The role of TGR5 as an onco-immunological biomarker in tumor staging and prognosis by encompassing the tumor microenvironment
por: Guan, Zhiyuan, et al.
Publicado: (2022)

Morphological Subtypes of Tumor Spread Through Air Spaces in Non-Small Cell Lung Cancer: Prognostic Heterogeneity and Its Underlying Mechanism
por: Xie, Huikang, et al.
Publicado: (2021)

SOCS3 Acts as an Onco-immunological Biomarker With Value in Assessing the Tumor Microenvironment, Pathological Staging, Histological Subtypes, Therapeutic Effect, and Prognoses of Several Types of Cancer
por: Dai, Lirui, et al.
Publicado: (2022)

Evaluating Heterogeneity of Primary Lung Tumor Using Clinical Routine Magnetic Resonance Imaging and a Tumor Heterogeneity Index
por: Hu, Nan, et al.
Publicado: (2021)

Born to be Alive: A Role for the BCL-2 Family in Melanoma Tumor Cell Survival, Apoptosis, and Treatment
por: Anvekar, Rina A., et al.
Publicado: (2011)

Tumor Cell-Based Vaccine Generated With High Hydrostatic Pressure Synergizes With Radiotherapy by Generating a Favorable Anti-tumor Immune Microenvironment
por: Seitz, Christoph, et al.
Publicado: (2019)

Development and Validation of a Novel Prognostic Model for Overall Survival in Newly Diagnosed Multiple Myeloma Integrating Tumor Burden and Comorbidities
por: Jia, Shuangshuang, et al.
Publicado: (2022)

From Tumor Cells to Endothelium and Gut Microbiome: A Complex Interaction Favoring the Metastasis Cascade
por: Abdel Sater, Ali H., et al.
Publicado: (2022)

Characteristics of Pan-Cancer Patients With Ultrahigh Tumor Mutation Burden
por: Yuan, Hong, et al.
Publicado: (2021)

Association of Tumor Lysis Syndrome and Metastatic Melanoma
por: Kelkar, Neil, et al.
Publicado: (2021)

The Impact of Hyaluronan on Tumor Progression in Cutaneous Melanoma
por: Takabe, Piia, et al.
Publicado: (2022)

The Presence of Circulating Tumor Cell Cluster Characterizes an Aggressive Hepatocellular Carcinoma Subtype
por: Yu, Jing-Jing, et al.
Publicado: (2021)

Tumor Mutational Burden Determined by Panel Sequencing Predicts Survival After Immunotherapy in Patients With Advanced Gastric Cancer
por: Kim, Jinchul, et al.
Publicado: (2020)

The Role of Autophagy in Tumor Immunology—Complex Mechanisms That May Be Explored Therapeutically
por: de Souza, Alana Serrano Campelo, et al.
Publicado: (2020)

Association between pH regulation of the tumor microenvironment and immunological state
por: Hosonuma, Masahiro, et al.
Publicado: (2023)

Tumor Mutational Burden Associated With Response to Hyperthermic Intraperitoneal Chemotherapy
por: Zeng, Lisi, et al.
Publicado: (2022)

Gastrointestinal stromal tumors (GISTs) with remarkable cystic change: a specific subtype of GISTs with relatively indolent behaviors and favorable prognoses
por: Xue, Anwei, et al.
Publicado: (2019)

Poor Lymphocyte Infiltration to Primary Tumors in Acral Lentiginous Melanoma and Mucosal Melanoma Compared to Cutaneous Melanoma
por: Nakamura, Yoshiyuki, et al.
Publicado: (2020)

Immune Checkpoint Gene Expression Profiling Identifies Programmed Cell Death Ligand-1 Centered Immunologic Subtypes of Oral and Squamous Cell Carcinoma With Favorable Survival
por: Yu, Yang, et al.
Publicado: (2022)

Systematic Chromatin Accessibility Analysis Based on Different Immunological Subtypes of Clear Cell Renal Cell Carcinoma
por: Zhang, Shiqiang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jm5g3r2m30u7orh7evmgkff6uo